Cascadian Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Cascadian Therapeutics, Inc. reported Increase (Decrease) in Deferred Revenue of -$145.00 thousand for the 3-month period ending 2011-03-31, per its 10-Q/A filed 2012-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2012-08-13
- Cascadian Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2011-03-31 was -$145.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month |
|---|---|
| 2011-03-31 | -$145.00K 10-Q/A · filed 2012-08-13 |